aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Nodexus, a startup originating from UC Berkeley and Stanford's StartX accelerator, focuses on commercializing cutting-edge technologies for advanced workflows in gene editing, cancer biology, agriculture, and more. Their flagship product, the NX One, is an affordable and flexible single-cell sorting and dispensing system designed to make high-precision cellular analysis accessible to a broader range of researchers and institutions.
The company has attracted notable figures in the field of flow cytometry to its Scientific Advisory Board, enhancing its expertise and credibility. Nodexus has achieved significant milestones, including the successful deployment of its technology in various high-impact research areas. By democratizing access to advanced cellular analysis tools, Nodexus is making a substantial impact on scientific research and innovation across multiple disciplines.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Laboratory Equipment
Technology
Biotech
Tags
Life Science
Model Types
Hardware, Software
Revenue Type(s)
Transactional
Customer Type(s)
Enterprise, Research
Geographic Exposure
Global
When was Nodexus founded?
Nodexus was founded in 2014.
Where is Nodexus's headquarters located?
Nodexus's headquarters is located in Berkeley, CA, US.
When was Nodexus's last funding round?
Nodexus's most recent funding round was for $30M (USD) in December 2021.
How many employees does Nodexus have?
Nodexus has 30 employees as of Feb 4, 2024.
How much has Nodexus raised to-date?
As of July 05, 2023, Nodexus has raised a total of $30M (USD) since Dec 16, 2021.
Add Comparison
Total Raised to Date
$30M
USD
Last Update Dec 16, 2021
Last Deal Details
$30M
USD
Dec 16, 2021
Series A
Total Employees Over Time
30
As of Feb 2024
Nodexus Address
2150 Shattuck Ave.
Ph
Berkeley,
California
94704
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts